News for 'Oxford United'

New IT minister says Twitter will have to abide by Indian laws

New IT minister says Twitter will have to abide by Indian laws

Rediff.com8 Jul 2021

All those who live and work in India will have to abide by the rules of the country, newly sworn-in Information and Technology Minister Ashwini Vaishnav said on Thursday on Twitter's standoff with the central government over new IT rules.

UK to add India's Covaxin to approved list from Nov 22

UK to add India's Covaxin to approved list from Nov 22

Rediff.com9 Nov 2021

The move follows the World Health Organisation's Emergency Use Listing for Covaxin, which is the second most used formulation in India.

'I have never used a teleprompter'

'I have never used a teleprompter'

Rediff.com24 Jan 2022

'In Hindi, Mr Modi is unequalled as an exceptionally accomplished orator.'

Will history repeat itself for Pakistan this Sunday?

Will history repeat itself for Pakistan this Sunday?

Rediff.com11 Nov 2022

If divine intervention in 1992 was the heavens opening up against England in their do-or-die game, even the best bookies couldn't have predicted that the Netherlands would beat South Africa in 2022. A handful of them must have made a killing.

J&J seeks permission for trial of 1-shot Covid vaccine in India

J&J seeks permission for trial of 1-shot Covid vaccine in India

Rediff.com20 Apr 2021

The US Food and Drug Administration had in February approved Johnson & Johnson's COVID-19 vaccine that works with just one dose for emergency use.

AstraZeneca's vaccine reaches phase 3 clinical trials: Trump

AstraZeneca's vaccine reaches phase 3 clinical trials: Trump

Rediff.com1 Sep 2020

The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services, which aims at accelerating the development and manufacturing of medical countermeasures for COVID-19 and delivering 300 million doses of an effective vaccine by January 2021.

Serum Institute gets nod to resume vaccine trial in India

Serum Institute gets nod to resume vaccine trial in India

Rediff.com16 Sep 2020

SII has been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

Rediff.com11 Sep 2020

The DCGI also directed Serum Institute of India to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report.

India may get COVID-19 vaccine by early 2021: Report

India may get COVID-19 vaccine by early 2021: Report

Rediff.com28 Aug 2020

While the vaccine could be available at $3-6 (Rs 225 to Rs 550) per dose, herd immunity might be two years away due to implementation challenges, it said, adding the experience in large scale adult vaccination programmes is thin.

Rishi Sunak likely to become first Indian-origin British PM today

Rishi Sunak likely to become first Indian-origin British PM today

Rediff.com24 Oct 2022

With the former prime minister stepping aside on Sunday night saying it was "simply not the right time" for his comeback, the prospect of a Diwali victory for Sunak cannot be ruled out.

'7 blood clot deaths after 18.1 mn jabs, AstraZeneca vaccine safe'

'7 blood clot deaths after 18.1 mn jabs, AstraZeneca vaccine safe'

Rediff.com3 Apr 2021

The Medicines and Healthcare Products Regulatory Agency said in its latest Yellow Card monitoring of the coronavirus vaccine programme this week that of the 18.1 million people who had the Oxford vaccine in the UK, 30 people developed blood clots and seven had died as of March 24.

COVID-19 reinfection 'very rare': ICMR DG

COVID-19 reinfection 'very rare': ICMR DG

Rediff.com15 Sep 2020

The remarks come amid suspected cases of COVID-19 reinfection being reported from abroad and from Indian states like Telangana, Karnataka, Gujarat, Punjab and Maharashtra.

British Indian ex-minister Alok Sharma knighted; 30 more PIOs to be honoured

British Indian ex-minister Alok Sharma knighted; 30 more PIOs to be honoured

Rediff.com31 Dec 2022

Sharma was the president of the conference, the first since the Paris Agreement of COP21 that expected parties to make enhanced commitments towards mitigating climate change.

G20 leaders agree to strengthen WHO to fast-track EUA for Covid vax: Goyal

G20 leaders agree to strengthen WHO to fast-track EUA for Covid vax: Goyal

Rediff.com31 Oct 2021

Briefing the media in Rome, Goyal said the Leaders adopted the 'Rome Declaration' at the G20 Summit and the communique gives a very strong message under the health section with the countries agreeing that the COVID-19 immunisation is a global public good.

India Must Be Proud Of Akumjung Pongen

India Must Be Proud Of Akumjung Pongen

Rediff.com23 Nov 2021

Akumjung Pongen, the first Rhodes scholar from Nagaland, shares his inspiring journey.

415 mn Indians exited poverty in 2005-21, UN calls it historic

415 mn Indians exited poverty in 2005-21, UN calls it historic

Rediff.com17 Oct 2022

The number of poor people in India fell by about 415 million between 2005-06 and 2019-21, a "historic change" and a demonstration that the Sustainable Development Goal target of reducing at least by half the proportion of men, women and children of all ages living in poverty by 2030 is possible to achieve, even at a large scale, according to the UN.

UK identifies new South African coronavirus variant

UK identifies new South African coronavirus variant

Rediff.com24 Dec 2020

Like the UK variant identified earlier, the new variant of the novel coronavirus is also driving a massive resurgence of the disease in South Africa, with experts warning the country is probably facing a much larger second wave.

UK eases travel restrictions for India

UK eases travel restrictions for India

Rediff.com8 Aug 2021

This means fully vaccinated Indian passengers will no longer be subjected to a compulsory 10-day hotel quarantine on their arrival in Britain.

J&J in talks with India for study of single-dose vaccine

J&J in talks with India for study of single-dose vaccine

Rediff.com9 Apr 2021

India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

With Hanuman image, Brazil Prez thanks PM Modi for COVID vaccines

With Hanuman image, Brazil Prez thanks PM Modi for COVID vaccines

Rediff.com23 Jan 2021

PM Modi said that it was an honour to be a trusted partner during the pandemic adding that the two countries will continue to strengthen cooperation on healthcare.

'Aggression over Covid vaccines is unprecedented'

'Aggression over Covid vaccines is unprecedented'

Rediff.com1 May 2021

CEO of Serum Institute of India hints that he may start producing in Britain and speaks about threatening calls from the rich and powerful

Will Rishi Sunak create history in his second comeback for PM race?

Will Rishi Sunak create history in his second comeback for PM race?

Rediff.com23 Oct 2022

While Sunak has maintained a dignified silence over the recent crisis, his supporters have not lost any opportunity to point out how the former finance minister had got the economic forecasts right.

Expert panel seeks more data on SII, Bharat Biotech vaccines

Expert panel seeks more data on SII, Bharat Biotech vaccines

Rediff.com10 Dec 2020

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.

COVID-19 vaccine will be available by year end, says Trump

COVID-19 vaccine will be available by year end, says Trump

Rediff.com4 May 2020

"I think we'll have a vaccine by the end of the year," Trump said at a Fox News virtual town hall. "We'll have a vaccine much sooner rather than later."

UK study finds Covid vaccine protection wanes in months

UK study finds Covid vaccine protection wanes in months

Rediff.com25 Aug 2021

The protection gained after being fully vaccinated with both doses of the Pfizer/BioNTech and Oxford/AstraZeneca vaccines against Covid-19 wanes over time, a new UK study reported on Wednesday.

Clinical trials of COVID-19 vaccine show promising early results: Experts

Clinical trials of COVID-19 vaccine show promising early results: Experts

Rediff.com21 May 2020

Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.

Is Britain Ready For Akshata Murty?

Is Britain Ready For Akshata Murty?

Rediff.com19 Jul 2022

Meet Sudha Murty and N R Narayana Murthy's daughter whose husband Rishi Sunak is the frontrunner to be Britain's next prime minister.

Covid vaccine to be available for every Indian till 2024: Poonawalla

Covid vaccine to be available for every Indian till 2024: Poonawalla

Rediff.com19 Nov 2020

Poonawalla said the price will be around USD 5-6 per dose with an MRP of around Rs 1,000 for the two necessary doses.

The A-W Of Desi Guests At the White House Dinner

The A-W Of Desi Guests At the White House Dinner

Rediff.com24 Jun 2023

The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.

AstraZeneca vaccine's chief investigator backs Covishield dose gap

AstraZeneca vaccine's chief investigator backs Covishield dose gap

Rediff.com18 Jun 2021

Backing the 12-16 weeks gap between the two doses of Covishield in the country, the chief investigator of the AstraZeneca vaccine clinical trials on Friday said that the level of protection provided by one dose of the preventive significantly increases in the second and third months after the jab.

Incident with volunteer no way induced by vaccine: Serum Institute

Incident with volunteer no way induced by vaccine: Serum Institute

Rediff.com1 Dec 2020

A Chennai-based man has demanded a compensation of Rs 5 crore from the SII after his health worsened allegedly after volunteering for the clinical trials for a COVID-19 vaccine.

Serum Institute to begin trials of COVID-19 vaccine in Mumbai, Pune

Serum Institute to begin trials of COVID-19 vaccine in Mumbai, Pune

Rediff.com23 Jul 2020

There are a number of trial sites across both Mumbai and Pune that we have shortlisted, as these cities have many hotspots, which will help us understand the efficacy of the vaccine, the company's chief executive Adar Poonawalla said.

Double vaccinated 3 times less likely to get COVID: Study

Double vaccinated 3 times less likely to get COVID: Study

Rediff.com6 Aug 2021

PHE estimates that the vaccination programme in England has prevented 22 million infections, around 52,600 hospitalisations and between 35,200 and 60,000 deaths.

Don't Expect Favours From Rishi

Don't Expect Favours From Rishi

Rediff.com27 Oct 2022

Some believe that, as prime minister, Sunak will be particularly friendly to India and that he would return the Kohinoor and do similar gestures to his motherland. Such wishful thinking is not likely to materialise as he will act in the best interests of the UK and will not even appear to favour India, argues Ambassador T P Sreenivasan.

Imran Khan becomes 1st Pak PM to lose no-trust vote

Imran Khan becomes 1st Pak PM to lose no-trust vote

Rediff.com10 Apr 2022

While in power, Khan repeatedly talked about making Pakistan an Islamic welfare state. However, he failed to fix the economy and the basic problem of keeping the prices of commodities in control.

Historic! Rishi Sunak to be UK's 1st Indian-origin PM

Historic! Rishi Sunak to be UK's 1st Indian-origin PM

Rediff.com24 Oct 2022

Rishi Sunak on Monday is all set to make history on Diwali as Britain's first Indian-origin prime minister after being elected unopposed as the new leader of the governing Conservative Party, following Penny Mordaunt's withdrawal from the race.

How to apply for Rhodes Scholarship 2017

How to apply for Rhodes Scholarship 2017

Rediff.com8 Jul 2016

Selected candidates will get to pursue a fully funded course of their choice at the University of Oxford.

Narayana Murthy's son-in-law named UK finance minister

Narayana Murthy's son-in-law named UK finance minister

Rediff.com14 Feb 2020

The MP for Richmond in Yorkshire, married to Murthy's daughter Akshata, first entered the UK Parliament in 2015 and has fast risen up the Conservative Party ranks as a staunch Brexiteer who had back Johnson's strategy to leave the European Union.

Amid backlash, UK says engaged with India on vax recognition

Amid backlash, UK says engaged with India on vax recognition

Rediff.com21 Sep 2021

The comments by a spokesperson in the British High Commission in New Delhi came amid concerns in India over the latest Covid-related travel restrictions announced by the UK.